Oncimmune® LLC, maker of EarlyCDT™-Lung, a simple blood test that aids physicians in the risk assessment and early detection of lung cancer, announces that an abstract (P4.013) "EarlyCDT-Lung test: audit of 1,000 patients in clinical practice" supports the previously published validation studies...